Eliza receives U.S. patent allowance for Complex Acoustic Resonance Speech Analysis System

Eliza Corporation ("Eliza"), the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.  The patent for the Complex Acoustic Resonance Speech Analysis System will be Eliza's fifteenth U.S. patent. Eliza's intellectual property covers a range of speech recognition technology (SRT), linguistic technology and high-performance interaction networks.  The patent issuance for the Complex Acoustic Resonance Speech Analysis System is an important addition to Eliza's growing patent portfolio, and underscores Eliza's non-stop dedication to delivering innovative technologies that address the opportunities and challenges in the healthcare space – today and in the future.

"Our growth and leadership in the Health Engagement Management market is powered by our continuous technology invention," said Lucas Merrow, Founder and CEO of Eliza Corporation.  "Eliza's patented technology enables us to deliver relevant, timely content through interactions that are incredibly lifelike, based on data-driven segmentation. These conversations are a key element to our "surround-sound" approach – coordinated, multi-modal outreach that lets us carefully monitor engagement across all channels, meet people where they are in their healthcare experience and connect them with the resources they need to make better health-related decisions."  

The Complex Acoustic Resonance Speech Analysis System further advances Eliza's industry-leading technology in simulating one-to-one human interactions. Conversational, high-performance speech recognition is fundamental to engaging consumers with automated interactions in healthcare. Eliza's unmatched linguistics-based engine understands a wide range of responses – so people can respond naturally and focus on the topic at hand – not detailed menus or usage instructions. As a result, the flexible interface translates to more effective interactions delivered at a scale that makes Eliza appropriate for all sizes of member populations. Eliza's technology also:

• Extends the reach and effectiveness of customers' existing resources, such as doctors, clinicians, nurses, etc. in ways that create healthier outcomes and greater value for a population than it costs, and considerably more value than alternatives.
• Engages individuals in a personable way about their health and healthy behavior.
• Points to resources and automate tasks and workflow. 

Recent announcements related to healthcare reform will continue to place quality Health Engagement Management strategies and supporting technologies at the top of every healthcare executive's priority list.  The sophistication of Eliza's technology creates a broad range of engagement strategies tailored to customers' needs for a wide array of health-related segments such as Accountable Care Organizations (ACOs), Commercial, Employers, Managed Care Organizations (MCOs), Medicare, Medicaid, Providers, Pharmacy Benefits Managers (PBMs), among others. 

"Since Eliza's customers are held accountable for the health, wellness, and costs of diverse populations, it's critical that the right technology is targeted at the right individual to improve consumer experiences and drive the greatest health and financial outcomes," adds Merrow. "Most individuals are aware and appreciate the difference between Eliza's quality outreach and other technologies. We consider it a point of pride when those interacting with Eliza say "thank you" at the end of the call.  That's the brass ring for which we strive – that wow-factor, that high level of engagement and appreciation for our technology."